molibresib   Click here for help

GtoPdb Ligand ID: 7033

Synonyms: CS-0717 | GSK 525762A | GSK-525762 | GSK525762 | I-BET-762 | I-BET762
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: I-BET compounds such as molibresib are acetyl histone mimetics.

According to GSK's pipeline web resource they have terminated development of molibresib in cancer, as their emerging data did not support progression.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 80.88
Molecular weight 423.15
XLogP 5.38
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCNC(=O)CC1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC
Isomeric SMILES CCNC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)ccc(c2)OC
InChI InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1
InChI Key AAAQFGUYHFJNHI-SFHVURJKSA-N
No information available.
Summary of Clinical Use Click here for help
Molibresib was evaluated for clinical efficacy against hematologic malignancies, NUT midline carcinoma (NMC) and other cancers (under its GSK reference code GSK525762), with several trials registered at ClinicalTrials.gov.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
This type of compound interferes with the process of 'reading' the acetylation status of histones by BET family bromodomain proteins (BRD2-4) [1].